Full List Of Stories
Verditek subsidiary moves forward with air purifier commercialisation
Clean technology company Verditek announced on Thursday that its wholly owned subsidiary, Westec Environmental Solutions (WES), has licensed a company to commercialise one of its products.
Proton Power Systems launches fourth generation fuel cells
Proton Power Systems announced the launch of its fourth generation of high efficiency stacks and fuel cell systems on Thursday.
US Treasury slaps sanctions on 19 Russians for "destabilising" cyber attacks
The US Treasury has imposed sanctions on 19 Russians who it accuses of involvement in interference in the 2016 US presidential race and other "ongoing nefarious attacks".
Water Intelligence aims to make a splash with California franchise
Water Intelligence has acquired its franchise in California for $252,000 after raising £4. 2m in a placing to fund several acquisitions, the company said on Thursday.
Zinc Media shares dip in spite of company's swing to profits
Zinc Media shares dropped over 10% despite the company have swung to a profit for the six months leading up to 31 December on the back of a 6% rise in revenues to £9. 76m.
Finance Industry attempts to tackle scams as consumers lose £236m
UK consumers lost £236m due to authorised push payment scams in 2017 as deception and impersonation continue to drive fraud according to data released by UK Finance on Thursday.
Georgian Mining subsidiary enters agreement and focuses on gold project
Georgian Mining Corp announced that its subsidiary company Georgian Copper & Gold (GCG) has entered into a memorandum of understanding (MOU) relating to a project in southern Georgia.
Russia 'soon' to expel British diplomats in Skripal poisoning spat
Russia will expel British diplomats "soon", foreign minister Sergei Lavrov said on Thursday, in retaliation to the UK’s response to the Salisbury poisoning of defector Sergei Skripal and his daughter Yulia.
Destiny Pharma lands 'fast track' designation for MRSA drug
Destiny Pharma has been granted fast-track designation by the US drug regulator for its lead clinical candidate.